Submit Feedback
Recent searches
    Trending searches
    +

    Merck & Co. Overview

    Company: Merck & Co.
    CEO: Mr. Robert M. Davis J.D.
    Symbol: MRK
    Exchange: NYSE
    Industry: Drug Manufacturers - General
    Sector: Healthcare
    About

    Merck & Co. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences to jointly develop and commercialize long-acting treatments in HIV. Merck & Co. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

    Continue reading...
    • Address:

      2000 Galloping Hill Road

    • City | State | Zip | Country:

      Kenilworth | NJ | 07033 | US

    • Phone:

      908 740 4000

    • Website:

      https://www.merck.com

    Merck & Co. (MRK)

    • Stock Price
    • Volume
    99.85 +14.48 +16.96%
    Past 5 Years
    • 1D
    • 1W
    • 1M
    • 3M
    • 6M
    • YTD
    • 1Y
    • 2Y
    • 5Y
    • 10Y
    • ALL

    Revenue

    Merck & Co. annual revenue was $60.12B in 2023.

    Net Income

    Merck & Co. annual net income was $365.00M in 2023.

    Employees

    Merck & Co. annual employee count was 72,000 in 2023.

    Revenue by Segment

    No Data Available !!

    Revenue by Region

    No Data Available !!

    Income Statement

    Operating Income

    Merck & Co. annual operating income was $2.95B in 2023.

    Research & Development

    Merck & Co. annual research & development expense was $30.53B in 2023.

    Tax Rate (%)

    Merck & Co. annual Tax Rate was 80.00% in 2023.

    Assets & Liabilities | Cash Flow

    Total Assets

    Merck & Co. annual total assets was $106.68B in 2023.

    Total Liabilities

    Merck & Co. annual total liabilities was $69.04B in 2023.

    Capital Expenditure

    Merck & Co. annual capital expenditures was -$3.86B in 2023.

    Ratios

    Return on Equity (ROE)

    Merck & Co. annual return on equity(ROE) was 0.97% in 2023.

    Return on Assets (ROA)

    Merck & Co. annual return on assets(ROA) was 0.34% in 2023.

    Debt to Equity

    Merck & Co. annual debt to equity was 93.28% in 2023.

    Profitability

    Gross Profit Margin (%)

    Merck & Co. annual gross profit margin was 73.17% in 2023.

    Operating Income Margin (%)

    Merck & Co. annual operating income margin was 4.91% in 2023.

    Net Income Margin (%)

    Merck & Co. annual net income margin was 0.61% in 2023.

    Earning Per Share

    Merck & Co. annual earning per share was $0.14 in 2023.

    EBITDA

    Merck & Co. annual EBITDA was $6.91B in 2023.

    Free Cash Flow (FCF)

    Merck & Co. annual free cash flow(FCF) was $9.14B in 2023.

    Valuation

    Enterprise value

    Merck & Co. annual enterprise value was $313.66B in 2023.

    Enterprise value to Revenue

    Merck & Co. annual enterprise value to revenue was 5.22 in 2023.

    Enterprise value to EBITDA

    Merck & Co. annual enterprise value to EBITDA was 45.41 in 2023.

    Competitors’ Revenue

    Related company

    Submit feedback to Bullfincher